Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question
This article was originally published in The Tan Sheet
Executive Summary
An initiative promoting Prilosec OTC over prescription competitors to help Medicare Part D users avoid "the coverage gap" in their prescription costs may prompt a closer look at ways Medicare can pay for OTCs